Cargando…
Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis
Patients with rheumatoid arthritis (RA) are treated with drugs that may impact their immune responses to SARS-CoV-2 vaccines. We describe here the anti-Spike (anti-S) IgG and neutralizing antibody responses induced by the mRNA-1273 SARS-CoV-2 vaccine in a 78-years-old patient with RA, who received a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402486/ https://www.ncbi.nlm.nih.gov/pubmed/34452007 http://dx.doi.org/10.3390/vaccines9080883 |
_version_ | 1783745801229434880 |
---|---|
author | Michiels, Yves Houhou-Fidouh, Nadhira Collin, Gilles Berger, Jérôme Kohli, Evelyne |
author_facet | Michiels, Yves Houhou-Fidouh, Nadhira Collin, Gilles Berger, Jérôme Kohli, Evelyne |
author_sort | Michiels, Yves |
collection | PubMed |
description | Patients with rheumatoid arthritis (RA) are treated with drugs that may impact their immune responses to SARS-CoV-2 vaccines. We describe here the anti-Spike (anti-S) IgG and neutralizing antibody responses induced by the mRNA-1273 SARS-CoV-2 vaccine in a 78-years-old patient with RA, who received a low-dose combination therapy of methotrexate and adalimumab, shortly before vaccine administration. Both near-normal and impaired immune responses to vaccines have been reported previously in patients treated with these drugs. Our case report shows that, even at low doses, combined methotrexate-adalimumab therapy can be associated with a weak immune response to the mRNA1273 vaccine in elderly patients. |
format | Online Article Text |
id | pubmed-8402486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84024862021-08-29 Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis Michiels, Yves Houhou-Fidouh, Nadhira Collin, Gilles Berger, Jérôme Kohli, Evelyne Vaccines (Basel) Case Report Patients with rheumatoid arthritis (RA) are treated with drugs that may impact their immune responses to SARS-CoV-2 vaccines. We describe here the anti-Spike (anti-S) IgG and neutralizing antibody responses induced by the mRNA-1273 SARS-CoV-2 vaccine in a 78-years-old patient with RA, who received a low-dose combination therapy of methotrexate and adalimumab, shortly before vaccine administration. Both near-normal and impaired immune responses to vaccines have been reported previously in patients treated with these drugs. Our case report shows that, even at low doses, combined methotrexate-adalimumab therapy can be associated with a weak immune response to the mRNA1273 vaccine in elderly patients. MDPI 2021-08-09 /pmc/articles/PMC8402486/ /pubmed/34452007 http://dx.doi.org/10.3390/vaccines9080883 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Michiels, Yves Houhou-Fidouh, Nadhira Collin, Gilles Berger, Jérôme Kohli, Evelyne Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis |
title | Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis |
title_full | Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis |
title_fullStr | Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis |
title_full_unstemmed | Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis |
title_short | Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis |
title_sort | impact of low-dose methotrexate–adalimumab combination therapy on the antibody response induced by the mrna-1273 sars-cov-2 vaccine: case of an elderly patient with rheumatoid arthritis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402486/ https://www.ncbi.nlm.nih.gov/pubmed/34452007 http://dx.doi.org/10.3390/vaccines9080883 |
work_keys_str_mv | AT michielsyves impactoflowdosemethotrexateadalimumabcombinationtherapyontheantibodyresponseinducedbythemrna1273sarscov2vaccinecaseofanelderlypatientwithrheumatoidarthritis AT houhoufidouhnadhira impactoflowdosemethotrexateadalimumabcombinationtherapyontheantibodyresponseinducedbythemrna1273sarscov2vaccinecaseofanelderlypatientwithrheumatoidarthritis AT collingilles impactoflowdosemethotrexateadalimumabcombinationtherapyontheantibodyresponseinducedbythemrna1273sarscov2vaccinecaseofanelderlypatientwithrheumatoidarthritis AT bergerjerome impactoflowdosemethotrexateadalimumabcombinationtherapyontheantibodyresponseinducedbythemrna1273sarscov2vaccinecaseofanelderlypatientwithrheumatoidarthritis AT kohlievelyne impactoflowdosemethotrexateadalimumabcombinationtherapyontheantibodyresponseinducedbythemrna1273sarscov2vaccinecaseofanelderlypatientwithrheumatoidarthritis |